F.i.s. Fabbrica Italiana Sintetici S.p.a.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Italy
- Registered address
- Via Massimo D'Antona, 13, Termoli, Campobasso 86039, Italy (ITA)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 3008347496 · DUNS 339689422
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-09-22
- VAIDrug Quality Assurance2021-09-17
- VAIDrug Quality Assurance2018-06-01
- NAIDrug Quality Assurance2015-05-29
- NAIDrug Quality Assurance2012-04-05
Drugs this plant is listed as making
1 distinct drugs across 2 products name this site in their FDA label.
- EmpagliflozinBoehringer Ingelheim Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.